Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Mar;95(3):964–972. doi: 10.1172/JCI117805

Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.

J Cao 1, R A Vescio 1, C H Hong 1, A Kim 1, A K Lichtenstein 1, J R Berenson 1
PMCID: PMC441428  PMID: 7883997

Abstract

Because it has been difficult to identify and separate malignant cells in human lymphoid malignancies, we have developed a flow cytometry-based fluorescent in situ hybridization (FISH) technique using immunoglobulin (Ig) heavy chain variable region (VH) gene probes. After obtaining the specific VH gene sequence expressed by the multiple myeloma IM-9 cell line and the malignant cells in five multiple myeloma patients, sense and antisense biotinylated single-stranded RNA probes were prepared by transcription from the malignant clone's VH DNA sequences. The cells from the IM-9 cell line and from the mononuclear bone marrow cells of multiple myeloma patients were fixed, hybridized with the above biotinylated RNA probes, incubated with streptavidin-phycoerythrin, and analyzed by FACS analysis. The myeloma cells stained positive with their own specific antisense VH biotinylated RNa probes, whereas sense and irrelevant antisense biotinylated probes demonstrated only background staining. Dilutional concentrations of the IM-9 cell line with normal bone marrow cells were also accurately quantitated by this procedure. The application of this technique will allow a more accurate assessment of tumor burden in patients with multiple myeloma and should permit an accurate method of tumor cell purification for clinical as well as biological studies. Furthermore, this technological advance should be equally effective at identifying specific VH gene-expressing cells in other lymphoid malignancies, as well as in nonmalignant B cell disorders.

Full text

PDF
964

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akhtar N., Ruprai A., Pringle J. H., Lauder I., Durrant S. T. In situ hybridization detection of light chain mRNA in routine bone marrow trephines from patients with suspected myeloma. Br J Haematol. 1989 Nov;73(3):296–301. doi: 10.1111/j.1365-2141.1989.tb07743.x. [DOI] [PubMed] [Google Scholar]
  2. Bagasra O., Seshamma T., Pomerantz R. J. Polymerase chain reaction in situ: intracellular amplification and detection of HIV-1 proviral DNA and other specific genes. J Immunol Methods. 1993 Jan 14;158(1):131–145. doi: 10.1016/0022-1759(93)90265-9. [DOI] [PubMed] [Google Scholar]
  3. Bakkus M. H., Heirman C., Van Riet I., Van Camp B., Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992 Nov 1;80(9):2326–2335. [PubMed] [Google Scholar]
  4. Bauman J. G., Bentvelzen P. Flow cytometric detection of ribosomal RNA in suspended cells by fluorescent in situ hybridization. Cytometry. 1988 Nov;9(6):517–524. doi: 10.1002/cyto.990090602. [DOI] [PubMed] [Google Scholar]
  5. Brahic M., Haase A. T. Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6125–6129. doi: 10.1073/pnas.75.12.6125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell M. J., Zelenetz A. D., Levy S., Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb;29(2):193–203. doi: 10.1016/0161-5890(92)90100-c. [DOI] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Deane M., Norton J. D. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias. Eur J Immunol. 1990 Oct;20(10):2209–2217. doi: 10.1002/eji.1830201009. [DOI] [PubMed] [Google Scholar]
  9. Embleton M. J., Gorochov G., Jones P. T., Winter G. In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells. Nucleic Acids Res. 1992 Aug 11;20(15):3831–3837. doi: 10.1093/nar/20.15.3831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greil R., Fasching B., Loidl P., Huber H. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis. Blood. 1991 Jul 1;78(1):180–191. [PubMed] [Google Scholar]
  11. Harper M. E., Marselle L. M. In situ hybridization--application to gene localization and RNA detection. Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):73–80. doi: 10.1016/0165-4608(86)90374-2. [DOI] [PubMed] [Google Scholar]
  12. Kawano M. M., Huang N., Harada H., Harada Y., Sakai A., Tanaka H., Iwato K., Kuramoto A. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993 Jul 15;82(2):564–570. [PubMed] [Google Scholar]
  13. Logtenberg T., Schutte M. E., Inghirami G., Berman J. E., Gmelig-Meyling F. H., Insel R. A., Knowles D. M., Alt F. W. Immunoglobulin VH gene expression in human B cell lines and tumors: biased VH gene expression in chronic lymphocytic leukemia. Int Immunol. 1989;1(4):362–366. doi: 10.1093/intimm/1.4.362. [DOI] [PubMed] [Google Scholar]
  14. Nawata Y., Stall A. M., Herzenberg L. A., Eugui E. M., Allison A. C. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes. Int Immunol. 1990;2(7):603–614. doi: 10.1093/intimm/2.7.603. [DOI] [PubMed] [Google Scholar]
  15. Orlandi R., Güssow D. H., Jones P. T., Winter G. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 May;86(10):3833–3837. doi: 10.1073/pnas.86.10.3833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Paige C. J., Wu G. E., Castiglia C. L. Detection of RNA transcripts in normal lymphoid and myeloid colonies. J Immunol Methods. 1986 Oct 23;93(1):37–43. doi: 10.1016/0022-1759(86)90430-8. [DOI] [PubMed] [Google Scholar]
  17. Randen I., Potter K. N., Li Y., Thompson K. M., Pascual V., Førre O., Natvig J. B., Capra J. D. Complementarity-determining region 2 is implicated in the binding of staphylococcal protein A to human immunoglobulin VHIII variable regions. Eur J Immunol. 1993 Oct;23(10):2682–2686. doi: 10.1002/eji.1830231044. [DOI] [PubMed] [Google Scholar]
  18. Ravichandran K. S., Semproni A. R., Goldsby R. A., Osborne B. A. Immunoglobulin VH usage analysis by fluorescent in situ hybridization and flow cytometry. J Immunol Methods. 1992 Aug 30;153(1-2):249–259. doi: 10.1016/0022-1759(92)90328-q. [DOI] [PubMed] [Google Scholar]
  19. Stevenson F. K., Bell A. J., Cusack R., Hamblin T. J., Slade C. J., Spellerberg M. B., Stevenson G. T. Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody. Blood. 1991 Mar 1;77(5):1071–1079. [PubMed] [Google Scholar]
  20. Takács L., Kovacs E. J., Smith M. R., Young H. A., Durum S. K. Detection of IL-1 alpha and IL-1 beta gene expression by in situ hybridization. Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse. J Immunol. 1988 Nov 1;141(9):3081–3095. [PubMed] [Google Scholar]
  21. Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol. 1992 Oct 5;227(3):776–798. doi: 10.1016/0022-2836(92)90223-7. [DOI] [PubMed] [Google Scholar]
  22. Tron V. A., Harley C. B., Caussy D., Sauder D. N. In situ detection of interleukin-1 mRNA in human monocytes. Mol Immunol. 1988 May;25(5):439–445. doi: 10.1016/0161-5890(88)90163-0. [DOI] [PubMed] [Google Scholar]
  23. Witzig T. E., Dhodapkar M. V., Kyle R. A., Greipp P. R. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer. 1993 Jul 1;72(1):108–113. doi: 10.1002/1097-0142(19930701)72:1<108::aid-cncr2820720121>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  24. van Boxel J. A., Buell D. N. IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classes. Nature. 1974 Oct 4;251(5474):443–444. doi: 10.1038/251443a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES